These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6278185)

  • 1. Partial agonistic action of morphine in the rat vas deferens.
    Ishii K; Yamamoto S; Muraki T; Kato R
    Jpn J Pharmacol; 1981 Dec; 31(6):905-9. PubMed ID: 6278185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitability ot beta-endorphin, morphine and catecholamines of the vas deferens of the rat at different stages of development.
    Huidobro-Toro JP; Miranda H
    Eur J Pharmacol; 1981 Nov; 76(1):115-8. PubMed ID: 6274671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic ethanol administration induces tolerance to morphine and to beta-endorphin responses in the rat vas deferens.
    Miranda H; Bustos G; Lara H
    Eur J Pharmacol; 1983 Feb; 87(2-3):291-6. PubMed ID: 6132827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between morphine and the opioid-like peptides in the rat vas deferens.
    Huidobro F; Huidobro-Toro JP; Miranda H
    Br J Pharmacol; 1980 Dec; 70(4):519-25. PubMed ID: 6258678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tolerance to the excitatory effect of morphine and cross-tolerance to the inhibitory action of beta-endorphin in the isolated rat vas deferens.
    Huidobro-Toro JP; Miranda H; Huidobro F
    Life Sci; 1981 Feb; 28(7):773-9. PubMed ID: 7194959
    [No Abstract]   [Full Text] [Related]  

  • 6. Excitatory and inhibitory effects of opiates in the rat vas deferens: a dual mechanism of opiate action.
    Jacquet YF
    Science; 1980 Oct; 210(4465):95-7. PubMed ID: 6158098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of pro-opiomelanocortin products on the rat vas deferens.
    Smock T
    Life Sci; 1986 Nov; 39(18):1651-5. PubMed ID: 3022090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biogenic amines and beta-endorphin responses in the rat vas deferens.
    Miranda H; Vergara JF; Rosselot F; Fernandez E
    Gen Pharmacol; 1982; 13(1):45-8. PubMed ID: 6277728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens and effects of opioids and catecholamines on the smooth muscle of the rat vas deferens.
    Miranda H; Perez E; Fernandez E; Rosselot F; Vergara JF; Wolstenholme WW; Zuazo A
    Pharmacology; 1985; 30(3):168-80. PubMed ID: 3156386
    [No Abstract]   [Full Text] [Related]  

  • 11. Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
    Huidobro-Toro JP; Way EL
    Br J Pharmacol; 1981 Nov; 74(3):681-94. PubMed ID: 6170377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphiceptin ( beta-casomorphin (1-4) amide): a peptide opioid antagonist in the field stimulated rat vas deferens.
    Day AR; Freer RJ; Liao CS
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):543-6. PubMed ID: 6275472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mixed agonist-antagonist properties of [Gln8-Gly31]-beta h-EP-Gly-Gly-NH2 and [Arg9,19,24,28,29]-beta h-EP in the rat vas deferens neuroeffector junction: studies with naloxone, beta-funaltrexamine and ICI 174,864.
    Valenzuela R; Li CH; Huidobro-Toro JP
    J Pharm Pharmacol; 1989 Feb; 41(2):92-6. PubMed ID: 2568435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.
    Hughes J; Kosterlitz HW; Leslie FM
    Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the inhibitory action of somatostatin in the electrically stimulated rat vas deferens.
    Magnan J; Regoli D; Quirion R; Lemaire S; St-Pierre S; Rioux F
    Eur J Pharmacol; 1979 May; 55(4):347-54. PubMed ID: 467493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic agonist effect of phentolamine in the rabbit vas deferens and rat cerebral cortex.
    Ennis C; Lattimer N
    J Pharm Pharmacol; 1984 Nov; 36(11):753-7. PubMed ID: 6150979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.